DDI (Effect of Metformin and Furosemide on Rosuvastatin PK)
Status:
Completed
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The primary objective of this trial is to investigate the relative bioavailability of
rosuvastatin when given alone (Reference treatment, R) compared to when given together with
one of the three different doses of metformin (10 mg, Test treatment 1 (T1); 50 mg (T2); 500
mg (T3)) or one of the two doses of furosemide (1 mg (T4); 5 mg (T5)).